BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

SILCOPHL

All Eps Dividend Board Agm Q1 Q2 Q3

SILCOPHL 23-Aug-2020

The Company has informed that the Company has signed its first export agreement with ZAID ELYAS ADIL LTD, Afghanistan. The Company will export total of 13 different medicines to Afghanistan for next 5 years commencing from August 2020. Total export value (estimated) will be 3,80,000.00 US Dollar. First export value (as per PI) will be 26,780.00 US Dollar against 13 different medicines to Afghanistan and estimated profit will be 30% against the export.

SILCOPHL 30-Jun-2020

(Q3 Un-audited): EPS was Tk. 0.25 for January-March 2020 as against Tk. 0.41 for January-March 2019; EPS was Tk. 0.76 for July 2019-March 2020 as against Tk. 1.07 for July 2018-March 2019. NOCFPS was Tk. 1.22 for July 2019-March 2020 as against Tk. 0.10 for July 2018-March 2019. NAV per share was Tk. 21.60 as on March 31, 2020 and Tk. 23.12 as on June 30, 2019.

SILCOPHL 24-Jun-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on June 29, 2020 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2020.

SILCOPHL 02-Feb-2020

DSE NEWS: The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase security of Silco Pharmaceuticals Limited in between 1st to 30th trading day after change of categorization, with effect from February 03, 2020 as per BSEC Directive No. SEC/CMRRCD/2009-193/177 and BSEC Order No. SEC/CMRRCD/2009-193/178 dated October 27, 2015.

SILCOPHL 02-Feb-2020

The Company will be placed in 'A' category from existing 'N' category with effect from February 03, 2020 as the Company has reported disbursement of 2% cash and 10% stock dividend for the year ended on June 30, 2019.

SILCOPHL 02-Feb-2020

The Company has informed that it has credited the Bonus shares for the year ended on June 30, 2019 to the respective shareholders' BO Accounts and it has also disbursed cash dividend to the respective shareholders.

SILCOPHL 02-Feb-2020

(Q2 Un-audited): EPS was Tk. 0.23 for October-December 2019 as against Tk. 0.34 for October-December 2018; EPS was Tk. 0.51 for July-December 2019 as against Tk. 0.65 for July-December 2018. NOCFPS was Tk. 1.00 for July-December 2019 as against Tk. 0.24 for July-December 2018. NAV per share was Tk. 21.35 as on June 30, 2019 and Tk. 23.12 as on June 30, 2019.

SILCOPHL 28-Jan-2020

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2020 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2019.

SILCOPHL 25-Nov-2019

The Company has further informed that due to unavoidable circumstances the Board of Directors has decided that, the 24th AGM of the Company will now be held on December 26, 2019 instead of earlier declared date December 12, 2019. Venue, time and all other information will remain unchanged.

SILCOPHL 19-Nov-2019

Trading of the Shares of the Company will resume on 20.11.2019 after record date.

Previous Next page